NursingNotes
  • login
  • signup
  • Latest News
  • Clinical Updates
  • Professional
  • Education
  • Opinion
No Result
View All Result
NursingNotes
No Result
View All Result

Home > News

Pregabalin and gabapentin will become controlled drugs in April


17 October 2018
Gabapentin

Shutterstock

Gabapentinoids, like gabapentin and pregabalin, are to become controlled drugs.

Prescription drugs pregabalin and gabapentin are to be reclassified as class C controlled substances from next April, the government has announced. Medications may also be known by their brand names; lyrica and neurontin.



The move comes after experts have highlighted rising numbers of fatalities linked to the drugs. The change means it will be illegal to possess pregabalin and gabapentin without a prescription and it will be illegal to supply or sell them to others.

The drugs, which are used to treat nerve pain, epilepsy and anxiety, can bring about an elevated mood in users but can also have serious side effects, particularly when used in combination with other drugs.

In 2016, the Advisory Council on the Misuse of Drugs (ACMD) raised concerns over medicinal misuse, illegal diversion of the drugs and addiction, and recommended that pregabalin and gabapentin should be controlled as class C Drugs under the Misuse of Drugs Act.

Stronger controls will be put into place.

Regulations implementing the change in law to control the drugs will be laid in Parliament later today.


Minister for Crime, Safeguarding and Vulnerability Victoria Atkins said: “Any death related to the misuse of drugs is a tragedy. We accepted expert advice and will now change the law to help prevent misuse of pregabalin and gabapentin and addiction to them.

“While drug misuse is lower now than it was 10 years ago, we remain committed to reducing it and the harm it causes.

“That is why we have published a comprehensive strategy to tackle the illicit drug trade, protect the most vulnerable and help those with drug dependency to recover and turn their lives around.”

The law change will mean the drugs are still available for legitimate use on prescription, but there will be stronger controls in place to ensure accountability and minimise the chances of pregabalin and gabapentin falling into the wrong hands or being stockpiled by patients.


Doctors will now need to physically sign prescriptions, rather than electronic copies being accepted by pharmacists. In addition, pharmacists must dispense the drugs within 28 days of the prescription being written.



Popular

Patient face mask in GP

GP practices can now deregister patients for ‘unrealistic service demands’

2 June 2022

student nurse staff nurse

Student nurses ‘used and abused’ on placements

13 June 2022

RCN

Nursing staff demand immediate review of ‘not fit for purpose’ Agenda for Change pay and conditions

8 June 2022

Insight

Busy A&E waiting room

‘The NHS is having its worst winter ever – and the reasons run much deeper than COVID’

28 January 2022

Hospital curtain intensive care

‘During the Downing Street Christmas Party we were caring for dying patients and forbidden from seeing family’

8 December 2021

Vaccine inPPE

‘Making vaccination compulsory for NHS frontline workers likely to make patients suffer’

19 November 2021


Related Posts

Close-up the positive young nurse who is dialing medicine into the syringe indoors
Clinical

Hospitals reintroduce compulsory mask wearing for staff and patients

29 June 2022
Nurse using computer night
Clinical

Virtual wards will free up hospital space and reduce staffing burden

29 June 2022
Official_portrait_of_Chris_Philp_MP
Workforce

MP incorrectly claims public sector pay has ‘kept up with inflation’

28 June 2022
NursingNotes

© 2019 NursingNotes.co.uk

Navigate Site

  • Who are we?
  • Terms of Service
  • Privacy Policy
  • Contact Us
  • Agenda for Change Pay Scales

Follow Us

No Result
View All Result
  • Latest News
  • Clinical
  • Education
  • Health Politics
  • Opinion
  • Resources

© 2019 NursingNotes.co.uk